Región de Valparaíso
Este organismo compró $424.402.363.698 en 183.163 órdenes de compra , sobre todo en Salud, servicios sanitarios y alimentación / Medicina y servicios de salud / Especialidades médicas y le compró principalmente a Inversiones e Inmobiliaria Rio Blanco S.A..
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $2570,5 M |
| 2025 | $14 mil M |
| 2024 | $9481,4 M |
| 2023 | $6078 M |
| 2022 | $5639,8 M |
| 2021 | $13,3 mil M |
| 2020 | $9390,1 M |
| 2019 | $15,8 mil M |
| 2018 | $23,6 mil M |
| 2017 | $15,2 mil M |
| 2016 | $16,8 mil M |
| 2015 | $13,7 mil M |
| 2014 | $10 mil M |
| 2013 | $39,8 mil M |
| 2012 | $8598,5 M |
| 2011 | $12,4 mil M |
| 2010 | $57,7 mil M |
| 2009 | $121,3 mil M |
| 2008 | $18,8 mil M |
| 2007 | $8501,8 M |
| 2006 | $1854 M |
Gasto en remedios comprados fuera de CENABAST cada segundo semestre, y la proyección H2-2026 (estacional). En verde, el sobreprecio evitable si se comprara vía CENABAST (~27%, conservador).
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 2200-143-AG26 | 17-04-2026 | Rosa Ibarra Bustos | Recepcion Conforme | $107.399 |
| 1634-1-SE26 | 16-04-2026 | Rnb Ingenieros SpA | Aceptada | $350.020.137 |
| 2200-148-TD26 | 16-04-2026 | Ingenieria en Climatizacion Alfredo Patricio Maureira Navarrete Empresa Individu | Aceptada | $132.087.199 |
| 2200-114-SE26 | 14-04-2026 | Grupo As Seguridad SpA | Recepcion Conforme | $342.720.000 |
| 1112555-11-SE26 | 14-04-2026 | Laboratorios Recalcine S.A. | Recepcion Conforme | $7.594.342 |
| 1112555-12-SE26 | 14-04-2026 | Ethon Pharmaceuticals Ltda. | Recepcion Conforme | $729.158 |
| 1112555-14-SE26 | 14-04-2026 | Itf Farma Chile S.A. | Recepcion Conforme | $180.880 |
| 1112555-5-SE26 | 14-04-2026 | Mdc Health SpA | Recepcion Conforme | $83.300 |
| 1112555-20-SE26 | 14-04-2026 | Galenicum Health Chile SpA | Recepcion Conforme | $1.326.374 |
| 1112555-18-SE26 | 14-04-2026 | Indopharma S.A. | Recepcion Conforme | $549.780 |
| 1112555-8-SE26 | 14-04-2026 | Opko Chile S.A. | Recepcion Conforme | $2.509.710 |
| 1112555-6-SE26 | 14-04-2026 | Scm Pharma SpA | Recepcion Conforme | $9.064.444 |
| 1112555-10-SE26 | 14-04-2026 | Instituto Sanitas S.A. | Recepcion Conforme | $1.999.200 |
| 1112555-15-SE26 | 14-04-2026 | Winpharm SpA | Recepcion Conforme | $214.200 |
| 1112555-13-SE26 | 14-04-2026 | Tecnofarma S.A. | Recepcion Conforme | $440.776 |
| 1112555-19-SE26 | 14-04-2026 | Laboratorios Andromaco S.A. | Recepcion Conforme | $1.911.140 |
| 1112555-16-SE26 | 14-04-2026 | Arama Natural Products Distribuidora Limitada | Recepcion Conforme | $640.220 |
| 1112555-21-SE26 | 14-04-2026 | Neoethicals Chile SpA | Recepcion Conforme | $903.924 |
| 1112555-7-SE26 | 14-04-2026 | Alembic Pharmaceuticals SpA | Recepcion Conforme | $4.064.802 |
| 1112555-9-SE26 | 14-04-2026 | Laboratorio Pasteur S.A. | Recepcion Conforme | $1.428.000 |
| 1112555-17-SE26 | 14-04-2026 | Ascend Laboratories SpA | Recepcion Conforme | $2.493.050 |
| 1112555-4-SE26 | 14-04-2026 | Laboratorio Chile S.A. | Recepcion Conforme | $6.369.594 |
| 2200-137-SE26 | 13-04-2026 | Servicios e Importaciones Alfaro y Pena Limitada | Aceptada | $17.314.500 |
| 1112555-1-SE26 | 09-04-2026 | Farmaceutica Caribean SpA | Recepcion Conforme | $5.896.498 |
| 1112555-3-SE26 | 09-04-2026 | Neoethicals Chile SpA | Recepcion Conforme | $1.117.481 |
| 2200-121-CM26 | 09-04-2026 | Comercial Odisea Limitada | Recepcion Conforme | $1.478.623 |
| 1112555-2-SE26 | 09-04-2026 | Exeltis Chile SpA | Recepcion Conforme | $10.495.800 |
| 2200-140-TD26 | 08-04-2026 | Sistemas Oracle de Chile S.A. | Recepcion Conforme | $5.471.470 |
| 2200-131-AG26 | 01-04-2026 | Delta Generacion SpA | Recepcion Conforme | $355.096 |
| 2200-132-AG26 | 01-04-2026 | Awad Articulos Medicos Limitada | Aceptada | $981.036 |
